Processa Pharmaceuticals Inc (PCSA)

Processa Pharmaceuticals Inc (PCSA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.1M; returns 1 day -2.7%, 1 week +7.1%, 1 year -76.4%.

Processa Pharmaceuticals Inc. (PCSA) is a clinical-stage biopharmaceutical company focused on developing Next Generation Chemotherapy (NGC) drugs and other therapies for life-threatening and life-compromising chronic diseases. Their core business model revolves around improving the safety and efficacy of existing FDA-approved oncology drugs by modifying their metabolism and/or distribution.

Groups PCSA belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Biopharmaceutical
• Healthcare
• Oncology
• Cancer Therapeutics
• Pharmaceuticals
• Clinical Stage
• Life Sciences
• Rare Diseases
• Breast Cancer Treatment

PCSA financial model: income statement, cash flow and balance sheet